Name
Osaühing Perearst Anne Kaldoja
Registry code
10944239
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
01.07.2003 (21)
Financial year
01.01-31.12
Capital
2 557.00 €
Activity
86211 - Provision of general medical treatment
418 688 €
-14 451 €
-3%
2 795 €
(estimate is approximate)
33 110 €
5
Submitted
No tax arrears
-44%
-16%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anne Kaldoja 10.10.1958 (66) | 100% - 2 557.00 EUR | Board member | Direct ownership | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ Räpina Tervisekeskus 14708866 | 20% - 500.00 EUR | - | - | Founder |
| 2019 26.05.2020 | 2020 31.05.2021 | 2021 16.06.2022 | 2022 10.05.2023 | 2023 30.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 303 492 € | 299 568 € | 310 298 € | 373 375 € | 418 688 € |
| Net profit (loss) for the period | 26 345 € | 38 655 € | 6 637 € | 21 204 € | -14 451 € |
| Profit Margin | 9% | 13% | 2% | 6% | -3% |
| Current Assets | 49 493 € | 80 575 € | 89 542 € | 90 757 € | 67 627 € |
| Fixed Assets | 7 700 € | 14 467 € | 42 681 € | 31 268 € | 24 985 € |
| Total Assets | 57 193 € | 95 042 € | 132 223 € | 122 025 € | 92 612 € |
| Current Liabilities | 24 534 € | 23 728 € | 38 181 € | 42 141 € | 53 854 € |
| Non Current Liabilities | - | - | 16 090 € | 10 728 € | 5 648 € |
| Total Liabilities | - | - | 54 271 € | 52 869 € | 59 502 € |
| Share Capital | - | - | - | - | - |
| Equity | 32 659 € | 71 314 € | 77 952 € | 69 156 € | 33 110 € |
| Employees | 4 | 5 | 5 | 5 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 20 493.17 € | 21 322.04 € | 8 |
| 2023 Q4 | - | 21 274.76 € | 21 949.5 € | 8 |
| 2023 Q3 | - | 27 561.41 € | 26 069.79 € | 6 |
| 2023 Q2 | - | 15 972.26 € | 16 362.95 € | 7 |
| 2023 Q1 | - | 22 179.4 € | 18 620.78 € | 6 |
| 2022 Q4 | - | 19 971.87 € | 18 106.13 € | 6 |
| 2022 Q3 | - | 18 290.59 € | 16 359.84 € | 6 |
| 2022 Q2 | - | 15 367.91 € | 15 858.43 € | 7 |
| 2022 Q1 | - | 17 655.66 € | 18 349.16 € | 8 |
| 2021 Q4 | - | 15 841.25 € | 16 504.02 € | 8 |
| 2021 Q3 | - | 13 358.43 € | 14 097.39 € | 8 |
| 2021 Q2 | - | 17 715.77 € | 18 656 € | 7 |
| 2021 Q1 | - | 11 882.03 € | 12 614.94 € | 6 |
| 2020 Q4 | - | 15 769.8 € | 16 797.61 € | 8 |
| 2020 Q3 | - | 10 047.77 € | 10 693.49 € | 8 |
| 2020 Q2 | - | 9 047.18 € | 9 594.37 € | 5 |
| 2020 Q1 | - | 11 049.47 € | 11 756.37 € | 5 |
